HealthStream, Inc. (NASDAQ:HSTM) has earned a consensus rating of “Hold” from the six ratings firms that are currently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, three have issued a hold rating and one has issued a strong buy rating on the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $29.00.
Several research firms have recently commented on HSTM. Barrington Research restated a “market perform” rating on shares of HealthStream in a research report on Thursday, July 25th. ValuEngine lowered shares of HealthStream from a “buy” rating to a “hold” rating in a research report on Wednesday, October 30th. Zacks Investment Research upgraded shares of HealthStream from a “hold” rating to a “strong-buy” rating and set a $32.00 price target for the company in a research report on Thursday, October 24th. Finally, BidaskClub lowered shares of HealthStream from a “hold” rating to a “sell” rating in a research report on Saturday, November 9th.
Shares of HealthStream stock traded down $0.32 during trading on Friday, hitting $26.89. 75,200 shares of the stock were exchanged, compared to its average volume of 125,491. The stock’s fifty day moving average is $26.90 and its 200 day moving average is $26.48. The stock has a market cap of $878.75 million, a PE ratio of 62.53, a P/E/G ratio of 5.48 and a beta of 0.64. The company has a debt-to-equity ratio of 0.09, a quick ratio of 2.24 and a current ratio of 2.24. HealthStream has a 12 month low of $23.06 and a 12 month high of $30.00.
In related news, Director Tate Deborah Taylor sold 6,495 shares of the stock in a transaction dated Thursday, October 31st. The shares were sold at an average price of $27.96, for a total value of $181,600.20. Following the completion of the transaction, the director now owns 16,181 shares in the company, valued at approximately $452,420.76. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 20.40% of the company’s stock.
Institutional investors and hedge funds have recently made changes to their positions in the stock. Tower Research Capital LLC TRC bought a new position in HealthStream in the 2nd quarter valued at about $44,000. Trustcore Financial Services LLC bought a new position in HealthStream in the 2nd quarter valued at about $78,000. Resources Investment Advisors LLC. grew its position in HealthStream by 13.0% in the 2nd quarter. Resources Investment Advisors LLC. now owns 3,900 shares of the technology company’s stock valued at $101,000 after buying an additional 450 shares in the last quarter. Aperio Group LLC bought a new position in HealthStream in the 2nd quarter valued at about $141,000. Finally, Meeder Asset Management Inc. grew its position in HealthStream by 412.9% in the 2nd quarter. Meeder Asset Management Inc. now owns 6,026 shares of the technology company’s stock valued at $156,000 after buying an additional 4,851 shares in the last quarter. Hedge funds and other institutional investors own 70.80% of the company’s stock.
HealthStream, Inc provides workforce and provider solutions for healthcare organizations in the United States. It operates through two segments, Workforce Solutions and Provider Solutions. The company offers workforce solutions, including software-as-a-service (SaaS) based services and subscription-based solutions to meet the training, certification, assessment, development, clinical development, talent management, performance appraisal, and other needs, as well as training, implementation, and account management services for the healthcare community.
Read More: QQQ ETF
Receive News & Ratings for HealthStream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthStream and related companies with MarketBeat.com's FREE daily email newsletter.